Differential mucosal expression of three superoxide dismutase isoforms in inflammatory bowel disease

Journal of Pathology

Volumn 201, Issue 1, 2003, Pages 7-16

  Kruidenier, Laurens ^a   Kuiper, Ineke ^a   van Duijn, Wim ^a   Marklund, Stefan L ^b   van Hogezand, Ruud A ^a   Lamers, Cornelis B H W ^a   Verspaget, Hein W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antioxidants; Crohn's disease; Immunohistochemistry; Inflammatory bowel disease; Oxidative stress; Superoxide dismutase; Ulcerative colitis

Indexed keywords

ANTIOXIDANT; COPPER ZINC SUPEROXIDE DISMUTASE; ISOENZYME; MANGANESE SUPEROXIDE DISMUTASE; SUPEROXIDE DISMUTASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LOCALIZATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE BIOPSY; INTESTINE EPITHELIUM CELL; INTESTINE MUCOSA; LAMINA PROPRIA; MACROPHAGE; MALE; NEUTROPHIL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; SPECTROPHOTOMETRY; STROMA CELL; TISSUE DISTRIBUTION; ULCERATIVE COLITIS;

ADULT; AGED; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; ISOENZYMES; MALE; MIDDLE AGED; SUPEROXIDE DISMUTASE;

EID: 0012169597     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1407     Document Type: Article

References (54)

1. Kruidenier L, Verspaget HW. Oxidative stress as a pathogenic factor in inflammatory bowel disease - radicals or ridiculous? Aliment Pharm Ther 2002; 16: 1997-2015.
2. Verspaget HW, Aparicio-Pagés MN, Verver S, et al. Influence of sulphasalazine and mesalazine on cellular and biochemical oxygen metabolite production. Effect of in vivo administration and an in vivo analysis. Scand J Gastroenterol 1991; 26: 779-786.
3. Simmonds NJ, Millar AD, Blake DR, Rampton DS. Antioxidant effects of aminosalicylates and potential new drugs for inflammatory bowel disease: assessment in cell-free systems and inflamed human colorectal biopsies. Aliment Pharm Ther 1999; 13: 363-372.
4. Zelko IN, Mariani TJ, Folz RJ. Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Rad Biol Med 2002; 33: 337-349.
5. Grisham MB, MacDermott RP, Deitch EA. Oxidant defense mechanisms in the human colon. Inflammation 1990; 14: 669-680.
6. Mulder TPJ, Verspaget HW, Janssens AR, de Bruin PAF, Griffioen G, Lamers CBHW. Neoplasia-related changes of two copper (Cu)/zinc (Zn) proteins in the human colon. Free Rad Biol Med 1990; 10: 501-506.
7. Janssen AML, Bosman CB, Kruidenier L, et al. Superoxide dismutases in the human colorectal cancer sequence. J Cancer Res Clin Oncol 1999; 125: 327-335.
8. Lih-Brody L, Powell SR, Collier KP, et al. Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig Dis Sci 1996; 41: 2078-2086.
9. Dagli Ü, Balk M, Yücel D, et al. The role of reactive oxygen metabolites in ulcerative colitis. Inflamm Bowel Dis 1997; 3: 260-264.
10. Mulder TPJ, Verspaget HW, Janssens AR, De Bruin PAF, Peňa AS, Lamers CBHW. Decrease in two intestinal copper/zinc containing proteins with anti-oxidant function in inflammatory bowel disease. Gut 1991; 32: 1146-1150.
11. Kruidenier L, Verspaget HW. Antioxidants and mucosa protectives: realistic therapeutic options in inflammatory bowel disease? Med Inflamm 1998; 7: 157-162.
12. Niwa Y, Somiya K, Michelson AM, Puget K. Effect of liposomal-encapsulated superoxide dismutase on active oxygen-related human disorders. A preliminary study. Free Rad Res Commun 1985; 1: 137-153.
13. Emerit J, Pelletier S, Tosoni-Verlignue D, Mollet M. Phase II trial of copper zinc superoxide dismutase (CuZnSOD) in treatment of Crohn's disease. Free Rad Biol Med 1989; 7: 145-149.
14. Sandström J, Karlsson K, Edlund T, Marklund SL. Heparin-affinity patterns and composition of extracellular superoxide dismutase in human plasma and tissues. Biochem J 1993; 294: 853-857.
15. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-275.
16. Tibell L, Hjalmarsson K, Edlund T, Skogman G, Engström Å, Marklund SL. Expression of human extracellular superoxide dismutase in Chinese hamster ovary cells and characterization of the product. Proc Natl Acad Sci U S A 1987; 84: 6634-6638.
17. Karlsson K, Marklund SL. Plasma clearance of human extra-cellular-superoxide dismutase C in rabbits. J Clin Invest 1988; 82: 762-766.
18. Janssen AML, Bosman CB, Sier CFM, et al. Superoxide dismutases in relation to the overall survival of colorectal cancer patients. Br J Cancer 1998; 78: 1051-1057.
19. McCord JM, Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 1969; 244: 6049-6055.
20. Verspaget HW, Peňa AS, Weterman IT, Lamers CBHW. Diminished neutrophil function in Crohn's disease and ulcerative colitis identified by decreased oxidative metabolism and low superoxide dismutase content. Gut 1988; 29: 223-228.
21. Götz JM, Van Kan CI, Verspaget HW, Biemond I, Lamers CBHW, Veenendaal RA. Gastric mucosal superoxide dismutases in Helicobacter pylori infection. Gut 1996; 38: 502-506.
22. Lakari E, Pääkkö P, Kinnula VL. Manganese superoxide dismutase, but not CuZn superoxide dismutase, is highly expressed in the granulomas of pulmonary sarcoidosis and extrinsic allergic alveolitis. Am J Respir Crit Care Med 1998; 158: 589-596.
23. Qi X, Guy J, Nick H, Valentine J, Rao N. Increase of manganese superoxide dismutase, but not of Cu/Zn-SOD, in experimental optic neuritis. Invest Ophthalmol Vis Sci 1997; 38: 1203-1212.
24. Tannahill CL, Stevenot SA, Campbell-Thompson M, Nick HS, Valentine JF. Induction and immunolocalization of manganese superoxide dismutase in acute acetic acid-induced colitis in the rat. Gastroenterology 1995; 109: 800-811.
25. Wong GH, Goeddel DV. Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism. Science 1988; 242: 941-944.
26. Valentine JF, Nick HS. Acute-phase induction of manganese superoxide dismutase in intestinal epithelial cell lines. Gastroenterology 1992; 103: 905-912.
27. Marklund SL. Regulation by cytokines of extracellular superoxide dismutase and other superoxide dismutase isoenzymes in fibroblasts. J Biol Chem 1992; 267: 6696-6701.
28. Schull S, Heintz NH, Periasamy M, et al. Differential regulation of antioxidant enzymes in response to oxidants. J Biol Chem 1991; 266: 24 398-24 403.
29. Strålin P, Marklund SL. Effects of oxidative stress on expression of extracellular superoxide dismutase, CuZn-superoxide dismutase and Mn-superoxide dismutase in human dermal fibroblasts. Biochem J 1994; 298: 347-352.
30. Meier B, Radeke HH, Selle S, et al. Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumour necrosis factor-alpha. Biochem J 1989; 263: 539-545.
31. Remick DG, Villarete L. Regulation of cytokine gene expression by reactive oxygen and reactive nitrogen intermediates. J Leukoc Biol 1996; 59: 471-475.
32. Iizuka S, Taniguchi N, Makita A. Enzyme-linked immunosorbent assay for human manganese-containing superoxide dismutase and its content in lung cancer. J Natl Cancer Inst 1984; 72: 1043-1048.
33. Chang L-Y, Kang B-H, Slot JW, Vincent R, Crapo JD. Immuno-cytochemical localization of the sites of superoxide dismutase induction by hyperoxia in rat lungs. Lab Invest 1995; 73: 29-39.
34. Aruoma OI, Halliwell B. Action of hypochlorous acid on the antioxidant protective enzymes superoxide dismutase, catalase and glutathione peroxidase. Biochem J 1987; 248: 973-976.
35. MacMillan-Crow LA, Crow JP, Kerby JD, Beckman JS, Thompson JA. Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proc Natl Acad Sci U S A 1996; 93: 11853-11858.
36. Yakamura F, Taka H, Fujimura T, Murayama K. Inactivation of human manganese-superoxide dismutase by peroxynitrite is caused by exclusive nitration of tyrosine 34 to 3-nitrotyrosine. J Biol Chem 1998; 273: 14085-14089.
37. Nathan CF. Neutrophil activation on biological surfaces. J Clin Invest 1987; 80: 1550-1560.
38. Martin CA, El-Sabban ME, Zhao L, Burakoff R, Homaidan FR. Adhesion and cytosolic dye transfer between macrophages and intestinal epithelial cells. Cell Adhes Commun 1998; 5: 83-95.
39. Wang P, Chen H, Qin H, et al. Overexpression of human copper, zinc-superoxide dismutase (SOD1) prevents postischemic injury. Proc Natl Acad Sci USA 1998; 95: 4556-4560.
40. Folz RJ, Abushamaa AM, Suliman HB. Extracellular superoxide dismutase in the airways of transgenic mice reduces inflammation and attenuates lung toxicity following hyperoxia. J Clin Invest 1999; 103: 1055-1066.
41. Kruidenier L, van Meeteren ME, Kuiper G, et al. Attenuated mild colonic inflammation and improved survival from severe DSS-colitis of transgenic Cu/Zn-SOD mice. Free Rad Biol Med 2003; 34: 753-765.
42. Wong GH, Elwell JH, Oberley LW, Goeddel DV. Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell 1989; 58: 923-931.
43. Hirose K, Longo DL, Oppenheirn JJ, Matsushima K. Overexpression of mitochondrial manganese superoxide dismutase promotes the survival of tumor cells exposed to interleukin-1, tumor necrosis factor, selected anticancer drugs, and ionizing radiation. FASEB J 1993; 7: 361-368.
44. Manna SK, Zhang HJ, Yan T, Oberley LW, Aggarwal BB. Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-κB and activated protein-1. J Biol Chem 1998; 273: 13 245-13 254.
45. Omar BA, Gad NM, Jordan MC, et al. Cardioprotection by Cu, Zn-superoxide dismutase is lost at high doses in the reoxygenated heart. Free Rad Biol Med 1990; 9: 465-471.
46. Omar BA, McCord JM. The cardioprotective effect of Mn-superoxide dismutase is lost at high doses in the postischemic isolated rabbit heart. Free Rad Biol Med 1990; 9: 473-478.
47. Virgili F, Canali R, Figus E, Vignolini F, Nobili F, Mengheri E. Intestinal damage induced by zinc deficiency is associated with enhanced CuZn superoxide dismutase activity in rats. Effects of dexamethasone or thyroxine treatment. Free Rad Biol Med 1999; 26: 1194-1201.
48. Amstad P, Peskin A, Shah G, et al. The balance between Cu, Zn-superoxide dismutase and catalase affects the sensitivity of mouse epidermal cells to oxidative stress. Biochemistry 1991; 30: 9305-9313.
49. de Haan JB, Cristiano F, Ianello R, Bladier C, Kelner MJ, Kola I. Elevation in the ratio of Cu/Zn-superoxide dismutase to glutathione peroxidase activity induces features of cellular senescence and this effect is mediated by hydrogen peroxide. Hum Mol Genet 1996; 5: 283-292.
50. Peled-Kamar M, Lotem J, Wirguin I, Weiner L, Hermalin A, Groner Y. Oxidative stress mediates impairment of muscle function in transgenic mice with elevated level of wild-type Cu/Zn superoxide dismutase. Proc Natl Acad Sci U S A 1997; 94: 3883-3887.
51. Krieglstein CF, Cerwinka WH, Laroux FS, et al. Regulation of murine intestinal inflammation by reactive metabolites of oxygen and nitrogen: divergent roles of superoxide and nitric oxide. J Exp Med 2001; 194: 1207-1218.
52. Brooksbank BWL, Balazs R. Superoxide dismutase, glutathione peroxidase and lipoperoxidation in Down's syndrome fetal brain. Brain Res 1984; 318: 37-44.
53. Picardo M, Grammatico P, Rocella F, et al. Imbalance in the antioxidant pool in melanoma cells and normal melanocytes from patients with melanoma. J Invest Dermatol 1996; 107: 322-326.
54. Gaetani P, Pasqualin A, Rodriguez y Baena R, Borasio E, Marzatico F. Oxidative stress in the human brain after subarachnoid hemorrhage. J Neurosurg 1998; 89: 748-754.